insights_auto
Pse është rritur INO 2,32%?
Zhytu më thellëchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
0,89Â US$
arrow_upward
+2,32%(+0,020) 1D
0,91Â US$
arrow_upward
+2,34% (+0,021)bedtimeJashtë orarit
Mbyllur: 27 tet, 4:00:01 m.d., GMT-4 · USD
search
TĂ« gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për INO...
Hap
0,88Â US$
I lartë
0,95Â US$
I ulët
0,86Â US$
Kapitalizimi i tregut
92,00Â mln
VĂ«llimi mesatar
3,55Â mln
VĂ«llimi
3,80Â mln
Maksimumi 52-javor
2,72Â US$
Minimumi 52-javor
0,57Â US$
Fitimet për aksion
-1,17Â US$
Beta
1,61
Aksionet në qarkullim
103,40Â mln
Numri i punonjësve
112
Hap
0,88Â US$
I lartë
0,95Â US$
I ulët
0,86Â US$
Kapitalizimi i tregut
92,00Â mln
VĂ«llimi mesatar
3,55Â mln
VĂ«llimi
3,80Â mln
Maksimumi 52-javor
2,72Â US$
Minimumi 52-javor
0,57Â US$
Fitimet për aksion
-1,17Â US$
Beta
1,61
Aksionet në qarkullim
103,40Â mln
Numri i punonjësve
112
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
www.marketscreener.com
·
3 orë më parë
Certain Stock Options of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 28-OCT-2026.
News Corp
·
7 orë më parë
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
MarketWatch
·
7 orë më parë
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Profili
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Rreth Inovio Pharmaceuticals Inc